联化科技：公司医药业务坚持大客户战略

Core Viewpoint - The company is focusing on a major client strategy in its pharmaceutical business, primarily through a CDMO business model, and has established partnerships with several leading global pharmaceutical companies [1] Group 1: Business Strategy - The company has adopted a CDMO (Contract Development and Manufacturing Organization) business model as its main approach in the pharmaceutical sector [1] - The company is actively expanding its client base by targeting strategic and high-viscosity clients [1] Group 2: Client Relationships - The pharmaceutical division has established stable commercial relationships with a number of high-quality domestic and international clients [1] - The scope of business cooperation is continuously expanding, and the depth of collaboration is increasing [1] Group 3: Future Growth Potential - The company is aligning its product pipeline with the business pipelines of its clients, which will enhance its technical capabilities [1] - Long-term growth in the pharmaceutical business is anticipated as the company continues to promote products during the patent periods of its clients [1]